Month: July 2021
-
Combined Therapy Shows Promise for Chronic Lymphocytic Leukemia
A combination therapy pairing a small molecule inhibitor with monoclonal antibody immunotherapy improved patient outcomes for relapsed chronic lymphocytic leukemia, according to a Northwestern Medicine clinical trial.
-
Novel Therapy May Improve Survival for Malignant Gliomas
A novel therapy developed by Northwestern Medicine investigators improved progression-free and overall survival for patients with newly diagnosed malignant gliomas, the most common primary brain tumors in adults.
-
Hasan Alam, MD: Trauma Trailblazer
Noted trauma surgeon Hasan Alam, MD, takes the reins of the Department of Surgery and as the Loyal and Edith Davis Professor of Surgery, and professor of Cell and Developmental Biology.
-
Northwestern Hospitals Among the Best in Latest U.S. News Rankings
Four Northwestern Medicine hospitals have been recognized by U.S. News & World Report in its 2020-21 Best Hospitals rankings, with Northwestern Memorial Hospital named among the top 10 hospitals in the U.S.
-
Tackling Disparities in Internal Medicine
Blessing Aghaulor, MD, MPH, a former resident in internal medicine and current fellow in Gastroenterology and Hepatology, has conducted research on transplant outcomes and consulted about patients at the ERASE trafficking clinic in Chicago.
-
Virtual Intervention Reduces Fear of Breast Cancer Recurrence
A targeted virtual health intervention was effective in reducing fear of recurrence among breast cancer survivors.
-
Evaluating Esophageal Hypervigilance and Symptom Anxiety
Measuring levels of hypervigilance and anxiety may improve healthcare providers’ understanding of severe esophageal diseases and treatment strategies, according to a Northwestern Medicine study.
-
Student Aims to Optimize Care Delivery
Medical student David Younessi recently authored a paper that highlighted price disparities between Medicare and VA reimbursements for several ophthalmic procedures.
-
Novel Treatments to Prevent Infections in Patients with Leukemia
Using universal myeloid progenitor cells or modified umbilical cord blood may help prevent infections in patients with leukemia, according to a pair of recent studies.
-
CARDIA Study Enters 35th Year
Thirty-five years since it was started, the Coronary Artery Risk Development in Young Adults study, or CARDIA, has become a premier source for the determinants, mechanism and outcomes of cardiovascular disease and manifestations of aging.
